 Peptides
"Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
| Descriptor ID |
D010455
|
| MeSH Number(s) |
D12.644
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptides".
Below are MeSH descriptors whose meaning is more specific than "Peptides".
This graph shows the total number of publications written about "Peptides" by people in this website by year, and whether "Peptides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 6 | 8 | | 1996 | 5 | 5 | 10 | | 1997 | 4 | 2 | 6 | | 1998 | 5 | 9 | 14 | | 1999 | 4 | 5 | 9 | | 2000 | 3 | 5 | 8 | | 2001 | 3 | 11 | 14 | | 2002 | 6 | 10 | 16 | | 2003 | 10 | 5 | 15 | | 2004 | 10 | 13 | 23 | | 2005 | 10 | 11 | 21 | | 2006 | 19 | 8 | 27 | | 2007 | 11 | 9 | 20 | | 2008 | 7 | 21 | 28 | | 2009 | 13 | 20 | 33 | | 2010 | 15 | 10 | 25 | | 2011 | 13 | 9 | 22 | | 2012 | 19 | 6 | 25 | | 2013 | 20 | 23 | 43 | | 2014 | 16 | 14 | 30 | | 2015 | 9 | 18 | 27 | | 2016 | 16 | 12 | 28 | | 2017 | 16 | 9 | 25 | | 2018 | 16 | 11 | 27 | | 2019 | 13 | 15 | 28 | | 2020 | 13 | 9 | 22 | | 2021 | 10 | 7 | 17 | | 2022 | 6 | 16 | 22 | | 2023 | 5 | 13 | 18 | | 2024 | 4 | 13 | 17 | | 2025 | 7 | 3 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Peptides" by people in Profiles.
-
Van Keuren AM, Simoes CT, Tucker CL. Chemical Control of Protease Activity and Gene Expression Using a Biotin-Released Inhibitory Domain. ACS Synth Biol. 2025 Aug 15; 14(8):3065-3077.
-
Rao DM, Horton ER, Barrington CL, Briney CA, Henriksen JC, Martinez-Seidel F, Morrison EJ, Sterling EM, Provencio ED, Harris M, Allen E, Hesselberth JR, Rissland OS. Systematic identification and characterization of eukaryotic and viral 2A peptide-bond-skipping sequences. Cell Rep. 2025 Jul 22; 44(7):115822.
-
Shi S, Li X, Alderman C, Wick L, Huang W, Foulon N, Zhang L, Rossi J, Hu W, Cui S, Zheng H, Taylor DJ, Ford HL, Zhao R. Cryo-EM structures reveal the PP2A-B55a and Eya3 interaction that can be disrupted by a peptide inhibitor. J Biol Chem. 2025 Jul; 301(7):110287.
-
Kolakada D, Fu R, Biziaev N, Shuvalov A, Lore M, Campbell AE, Cortázar MA, Sajek MP, Hesselberth JR, Mukherjee N, Alkalaeva E, Coban-Akdemir ZH, Jagannathan S. Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay. Cell Genom. 2025 Jul 09; 5(7):100882.
-
Bernstein JS, Canon N, Schein CH, Braun W, Negi SS, Tchekmedyian R, Pozzoli M, Kim EH, Kulis MD, Vu T, Liu W, Chen X, Dreskin SC. Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding. J Allergy Clin Immunol. 2025 Aug; 156(2):385-393.
-
Smith CF, Baldé MA, French S, Modahl CM, Bahrabadi L, Amponsah-Asamoah M, Larson KY, Maroney SP, Galindo DC, Millimouno M, Camara N, Benjamin J, Brandehoff NP, McCabe MC, Cohen MJ, Jackson K, Baldé C, Castoe TA, Mackessy SP, Hansen KC, Saviola AJ. Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics. J Thromb Haemost. 2025 Jul; 23(7):2198-2212.
-
Currie J, Ng DCM, Pandi B, Black A, Manda V, Durham C, Pavelka J, Lam MPY, Lau E. Improved Method to Determine Protein Turnover Rates with Heavy Water Labeling by Mass Isotopomer Ratio Selection. J Proteome Res. 2025 Apr 04; 24(4):1992-2005.
-
Shah VN, Dex T, Meneghini L, Rodrigues A, Polonsky WH. Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 May; 27(5):2523-2530.
-
Frías JP, Ratzki-Leewing A, Dex T, Meneghini L, Rodrigues A, Shah VN. Effect of iGlarLixi on continuous glucose monitoring-measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 Apr; 27(4):2173-2182.
-
Stokes EG, Vasquez JJ, Azouz G, Nguyen M, Tierno A, Zhuang Y, Galinato VM, Hui M, Toledano M, Tyler I, Shi X, Hunt RF, Aoto J, Beier KT. Cationic peptides cause memory loss through endophilin-mediated endocytosis. Nature. 2025 Feb; 638(8050):479-489.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|